Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy

Victoria Ling, Alan Burnett, Kenneth F Bradstock, John Seymour, Robert K Hills, Andrew Wei

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)861 - 863
Number of pages3
JournalBritish Journal of Haematology
Volume160
Issue number6
DOIs
Publication statusPublished - 2013

Cite this